Safety and Efficacy of Opicinumab in Acute Optic Neuritis (RENEW): A Randomised, Placebo-Controlled, Phase 2 Trial
The Lancet Neurology - United Kingdom
doi 10.1016/s1474-4422(16)30377-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2017
Authors
Publisher
Elsevier BV